EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Drug Resistance in Multiple Myeloma: Tumor‐Intrinsic Mechanisms and the Bone Marrow Microenvironment

Yixuan Chen iD, Wenming Huang iD, Mingxuan Tang iD, Xiaotao Wang iD

Cell Biochemistry and Function · 2026

DOI: 10.1002/cbf.70286 ↗

At a glance

Übersichtsarbeit in Cell Biochemistry and Function, 2026. Written by Yixuan Chen and 3 co-authors. Institution: Laboratory of Hematology, Guilin Medical University, Guilin, China. Major MEDLINE topics: Multiple Myeloma, Tumor Microenvironment, Drug Resistance, Neoplasm, Bone Marrow. 113 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Multiple myeloma (MM) is a malignant plasma cell disorder, and despite substantial improvements in prognosis achieved through chemotherapy, immunotherapy, and autologous stem cell transplantation, most patients ultimately develop relapsed or refractory disease. Drug resistance (DR) is increasingly recognized as a dynamically evolving ecosystem shaped by tumor‐intrinsic plasticity and continuous remodeling of the bone marrow microenvironment (BMME), rather than as a single molecular lesion. This review summarizes the major mechanisms of resistance across key drug classes, including alterations in drug targets and signaling nodes, rewiring of apoptotic, proteostatic, and metabolic circuits, and BMME‐dependent protection. We highlight how these processes converge on a limited set of survival hubs and collectively raise the apoptotic threshold under therapeutic pressure. The key to overcoming DR is to conceptualize it as an evolving ecosystem, thereby enabling rational, mechanism‐based combination and sequencing strategies that may prolong progression‐free survival and move MM closer to a functional cure.

Subjects

MeSH terms (MEDLINE)

Multiple MyelomaTumor MicroenvironmentDrug Resistance, NeoplasmBone MarrowAntineoplastic AgentsHumansAnimalsSignal Transduction

Author keywords

bone marrow microenvironmentcell communicationdrug resistanceimmunotherapymultiple myelomasignal transduction

Substances

Antineoplastic Agents

Authors and institutions

  • Laboratory of Hematology, Guilin Medical University, Guilin, China.
  • Department of Hematology, The First Affiliated Hospital of Guilin Medical University, Guilin, China.

ORCID profiles: Yixuan Chen, Wenming Huang, Mingxuan Tang, Xiaotao Wang

Funding

  • National Natural Science Foundation of China

Cite

APA

Chen, Y., Huang, W., Tang, M., & Wang, X. (2026). Drug Resistance in Multiple Myeloma: Tumor‐Intrinsic Mechanisms and the Bone Marrow Microenvironment. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.70286

Vancouver

Chen Y, Huang W, Tang M, Wang X. Drug Resistance in Multiple Myeloma: Tumor‐Intrinsic Mechanisms and the Bone Marrow Microenvironment. Cell Biochemistry and Function. 2026. doi:10.1002/cbf.70286

BibTeX
@article{Chen2026,
  author = {Chen, Yixuan and Huang, Wenming and Tang, Mingxuan and Wang, Xiaotao},
  title = {Drug Resistance in Multiple Myeloma: Tumor‐Intrinsic Mechanisms and the Bone Marrow Microenvironment},
  journal = {Cell Biochemistry and Function},
  year = {2026},
  doi = {10.1002/cbf.70286}
}
Start for free →